Picture of Baronsmead Venture Trust logo

BVT — Baronsmead Venture Trust News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsConservativeSmall Cap

Baronsmead Venture - Half-yearly Report

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230613:nRSM4622Ca&default-theme=true

RNS Number : 4622C  Baronsmead Venture Trust PLC  13 June 2023

Baronsmead Venture Trust plc

Half-yearly report for the six months ended 31 March 2023

The Directors of Baronsmead Venture Trust plc are pleased to announce the
unaudited half-yearly financial report for the six months to 31 March 2023.
Copies of the half-yearly report can be obtained from the following
website: www.baronsmeadvcts.co.uk (http://www.baronsmeadvcts.co.uk/) .

Our investment objective

·      Baronsmead Venture Trust plc (the "Company") is a tax efficient
listed company which aims to achieve long-term investment returns for private
investors, including tax-free dividends.

 

Investment policy

·      To invest primarily in a diverse portfolio of UK growth
businesses, whether unquoted or traded on the Alternative Investment Market
("AIM").

·      Investments are made selectively across a range of sectors in
companies that have the potential to grow and enhance their value.

 

Dividend policy

·      The Board will, wherever possible, seek to pay two dividends to
shareholders in each financial year, typically an interim dividend in
September and a final dividend following the Annual General Meeting.

·      The Board will use, as a guide, when setting the dividends for a
financial year, a sum representing 7 per cent. of the opening NAV of that
financial year.

 

Key elements of the business model

Access to an attractive, diverse portfolio

The Company gives shareholders access to a diverse portfolio of growth
businesses.

The Company will make investments in growth businesses, whether unquoted or
traded on AIM, which are substantially based in the UK in accordance with the
prevailing VCT legislation. Investments are made selectively across a range of
sectors.

 

The Manager's approach to investing

The Manager endeavours to select the best opportunities and applies a
distinctive selection criteria based on:

·      Primarily investing in parts of the economy which are
experiencing long term structural growth.

·      Businesses that demonstrate, or have the potential for, market
leadership in their niche.

·      Management teams that can develop and deliver profitable and
sustainable growth.

·      Companies with the potential to become an attractive asset
appealing to a range of buyers at the appropriate time to sell

In order to ensure a strong pipeline of opportunities, the Manager invests in
building deep sector knowledge, networks and undertakes significant active
marketing to target companies in preferred sectors. This approach generates a
network of potentially suitable businesses with which the Manager maintains a
relationship ahead of possible investment opportunities.

 

 

 

The Manager as an influential shareholder

The Manager is an engaged and supportive shareholder (on behalf of the
Company) in both unquoted and significant quoted investments.

 

For unquoted investments, representatives of the Manager often join the
investee board. The role of the Manager with investees is to ensure that
strategy is clear, the business plan can be implemented and the management
resources are in place to deliver profitable growth. The aim is to build on
the business model and grow the company into an attractive target which can be
sold or potentially floated in the medium term.

Financial highlights

400.9p Net asset Value ("NAV") total return to shareholders for every 100.0p
invested at launch (April 1998).

NAV per share decreased 0.9 per cent. to 58.0p before deduction of dividends
in the six months to 31 March 2023.

£25.0mn raised in the period (before costs).

£4.3mn Investments made into two new and three follow-on opportunities
during the period (Unquoted: £3.2mn, Quoted : £1.1mn).

Cash returned to shareholders by date of investment

 

The table below shows the cash returned to shareholders that invested in
Baronsmead Venture Trust plc dependent on their subscription cost, including
the income tax available to be reclaimed on the subscription.

 

 Year subscribed             Cash invested  Income tax reclaim                      Cumulative dividends  Return on cash invested(#) (%)

                              (p)           (p)                 Net cash invested   paid(#)

                                                                (p)                  (p)
 1998 (April)                100.00         20.00               80.00               181.40                201.4
 1999 (May)                  102.00         20.40               81.60               177.90                194.4
 2000 (February)             137.00         27.40               109.60              174.70                147.5
 2000 (March)                130.00         26.00               104.00              174.70                154.4
 2004 (October) - C shares*  100.00         40.00               60.00               130.00                170.0
 2009 (April)                91.60          27.48               64.12               113.50                153.9
 2012 (December)             111.80         33.54               78.26               88.00                 108.7
 2014 (March)                103.80         31.14               72.66               70.50                 97.9
 2016 (February)             102.80         30.84               71.96               56.00                 84.5
 2017 (October)              94.76          28.43               66.33               38.00                 70.1
 2019 (February)             84.20          25.26               58.94               31.50                 67.4
 2019 (November)             76.80          23.04               53.76               24.00                 61.3
 2020 (January)              82.40          24.72               57.68               24.00                 59.1
 2020 (February)             80.10          24.03               56.07               20.50                 55.6
 2020 (March)                63.80          19.14               44.66               20.50                 62.1
 2020 (November)             75.20          22.56               52.64               17.50                 53.3
 2020 (December)             78.00          23.40               54.60               17.50                 52.4
 2021 (January)              81.30          24.39               56.91               17.50                 51.5
 2021 (February)             78.80          23.64               55.16               14.00                                    47.8
 2021 (March)                80.90          24.27               56.63               14.00                 47.3
 2021 (December)             83.10          24.93               58.17               11.00                 43.2
 2022 (January)              82.40          24.72               57.68               11.00                 43.3
 2022 (March)                72.60          21.78               50.82               7.50                  40.3
 2023 (January)              64.25          19.28               44.97               4.50                  37.0
 2023 (March)                62.65          18.80               43.85               1.75                  32.8

 

* C Share dividend calculated using conversion ratio of 0.9657, which is the
rate the c shares were converted into ordinary shares.

* Includes proposed Interim dividend of 1.75p.

 * Shares were allotted pursuant to the 2023 Offer at individual prices for
each investor in accordance with the allotment formula as set out in each
Offer's Securities Note.

1.  Average effective offer price based on allotment prices between 63.4p and
67.2p.2. Average effective offer price based on allotment prices between 61.5p
and 64.5p.

Chair's statement

Fiona Miller Smith

Chair

Over what has been a turbulent six months, the Company's net asset value (NAV)
declined slightly by 0.5p per share to 58.0p. Continued weakness in the value
of the Company's unquoted investments was largely although not completely
offset by the modestly positive performance of the listed portfolio. This is
described more fully below, and highlights the benefits of the Company's
investment policy of having a combination of unquoted and listed assets with
the aim of providing a more consistent total return to shareholders over the
medium to long term. After the period end, NAV recovered through further good
performance of the listed portfolio, as reported on below.

Over the six months to 31 March 2023, inflation in the UK remained high and
interest rates rose steadily. Consequently, UK economic conditions continued
to be challenging and this has generated much uncertainty across the financial
markets. This was compounded in the first quarter of 2023 by the collapses of
Silicon Valley Bank and Credit Suisse in close succession which led to fears
of a more widespread banking sector contagion.

At the time of writing, it's fair to say that consumer and business confidence
remain fragile. In such an environment we might expect there to be further
weakness in the valuation of smaller companies and this is particularly the
case with the types of business the VCT rules require the Company to invest
in. However, the Manager continues to believe that, in aggregate, the

fundamentals of the underlying portfolio companies remain robust and the
growth prospects for the majority of investee companies continue to be
positive over the medium term.

Results

During the six months to 31 March 2023, the Company's NAV per share decreased
0.9 per cent. from 58.5p to 58.0p after the payment of a final dividend of
2.75p per share on 3 March 2023. The table below breaks down the movement in
NAV over the six months.

                                                                          Pence per ordinary share

 NAV as at 1 October 2022 (after deducting the final dividend of 2.75p)   58.5
 Valuation decrease (0.9 per cent.)                                       (0.5)
 NAV as at 31 March 2023                                                  58.0

 

 

The Board is pleased to report that over the two months to 31 May 2023, NAV
was 59.1p per share, a 1.9 per cent. increase over the NAV as at 31 March
2023. This was driven by firmer quoted markets and further increases in the
value of the Company's listed investments.

Dividends

The Board is pleased to declare an interim dividend of 1.75p per share to be
paid on 8 September 2023 to shareholders on the register as of 11 August 2023.
The Board is aware that dividends are an important part of the total return to
the shareholders' investment in the Company. As such, the Board is aiming to
achieve its dividend policy objective of an annual yield of 7.0 per cent.
based on the NAV at the beginning of the financial year. Having said that, I
must of course remind shareholders this is not a guarantee and that payment
dates and the amount of future dividends depend on the level and timing of
profitable realisations.

 

Portfolio review

The table below provides a summary of each asset class and the return
generated during the period under review.

 Asset class                                 NAV*     % of NAV*  Number of investees companies**  % return in the period***

                                             (£mn)
 Unquoted                                    44       22         41                               (14)
 AIM- traded companies                       59       29         48                               2
 LF Gresham House UK Micro Cap Fund          29       14         48                               7
 LF Gresham House UK Multi Cap Income Fund   12       6          40                               7
 LF Gresham House UK Smaller Companies Fund  25       12         38                               5
 Liquid assets(#)                            34       17         N/A                              2
 Total                                       203      100        215                              (1)

 

*By value at 31 March 2023.
**Includes investee companies with holdings by more than one fund. Total
number of individual companies held is 166.
***Return includes interest received on unquoted realisations during the
period.
(#)( )Represents cash, OEICs and net current assets. % return in the period
relates only to the OEICs.

The value of the unquoted portfolio decreased 13.6 per cent. in the six months
to 31 March 2023. The drop in value was driven by a combination of lower
benchmark market comparables and softening trading performance of the investee
companies as a result of the decline in consumer confidence.

 

The value of the Company's portfolio of investments directly held in
AIM-traded companies increased 2.1 per cent. in the six months to 31 March
2023. The value of the Company's investment into the LF Gresham House UK Micro
Cap Fund ("Micro Cap") increased by 7.4 per cent., the LF Gresham House UK
Smaller Companies Fund ("Small Cap") increased by 4.6 per cent. and the LF
Gresham House Multi Cap Income Fund increased by 6.8 per cent. in the period.
This was primarily due to positive news flow across the portfolio being well
received by the markets with a number of trading updates demonstrating better
than expected financial performance. In the Manager's regular reporting to the
Board, the Directors were pleased to learn that in the six months to 31 March
2023, 85.8 per cent. of the companies in our listed portfolio have reported
positive news flow in terms of the financial performance. This is very welcome
news given the economic and political uncertainties we are currently
experiencing.

 

Investments

I am pleased to report that the Company made two new investments totalling
£1.3mn and three follow-on investments with a combined value of £3.0mn in
the six months to 31 March 2023. Below are descriptions of the new investments
made:

 

·      Cognassist (unquoted) -a platform for supporting those with
learning needs.

 

·      Connect Earth (unquoted) - helps businesses track their carbon
emissions.

 

·      Patchworks (unquoted) - a platform for connecting businesses'
applications.

 

·      Oberon (quoted) - wealth advisory service for individuals and
businesses.

 

·      Seeen (quoted) - a video technology business.

Following the period end, a total of £1.8mn was invested as follows:

·      a new unquoted investment of £0.8mn in Dayrize, a platform for
assessing the sustainability of products,

 

·      a follow‑on investment of £0.6mn into Airfinity, which is in
our unquoted portfolio, and

 

·      a follow‑on investment of £0.4mn into Panthera Biopartners,
which is in our unquoted portfolio

Realisations

During the period both Glisser, a provider of conference and educational
software and CMME, a specialist mortgage broker, went into administration.
Both businesses had experienced very challenging trading conditions over the
past year and their valuations had already been written down.

Following the period end, in the unquoted portfolio, Evotix was acquired
resulting in a gross money multiple of 0.7x original cost. In addition,
further proceeds from previous sales of unquoted investments were received as
follows:

·      deferred consideration from the sale of Key Travel in 2018,
resulting in a gross money multiple of 3.2x original cost, and

·      earn‑out consideration from the Pho realisation in 2021,
resulted in a gross money multiple of 3.1x original cost.

In the listed portfolio, the Manager continued to take profits from partial
sales of the Company's holding of Cerillion plc resulting in proceeds of
£0.5mn, and a gross money multiple of 15.8x original cost.

Fundraising

I am pleased to report that during the period the Company successfully raised
£25.0mn (before costs) through an offer for subscription which became fully
subscribed in March 2023. The Directors are pleased to welcome the 873 new
shareholders who invested for the first time and to thank the 478 existing
shareholders who continue to support the Company.

The Board will consider whether to raise new funds in the 2023/24 tax year.
This will be determined by the Company's cashflow and its anticipated
requirements to fund new and follow‑on investments over the next two to
three years. The Board appreciates that shareholders would like plenty
ofnotice of its fundraising intentions and will ensure that shareholders are
informed of any such fundraising at the earliest practical time.

Consumer Duty

The Financial Conduct Authority (FCA) has introduced the concept of Consumer
Duty, the rules and principles of which come into effect in July 2023.
Consumer Duty is an advance on the existing concept of 'treating customers
fairly' and looks to ensure good outcomes for purchasers of investment
products. As a listed entity, Baronsmead Venture Trust plc, alongside other
investment companies, are not themselves subject to Consumer Duty.

Instead, in their role as promoter of and Investment Manager to the Company,
it is Gresham House, and any other FCA regulated parties associated with your
investment in the Company, that must uphold the principles behind Consumer
Duty. To that end, the Board is working with Gresham House to review the
information that should be provided to assist investors and their advisers to
discharge their obligations under Consumer Duty.

VCT Regulation - Financial Heath Test

 

Since the various VCT rule changes in both 2015 and 2018, VCT qualifying
investments have become focussed on smaller, younger companies. As a result,
when the Manager makes a new investment, they expect to make further follow-on
investments as the investee company progresses and where the business case for
the investment is justified. These follow-on investments are subject to the
same VCT compliance rules as new deals and both rely on certain criteria being
met, including the Financial Health Test.

 

The Financial Health Test is not something new and was primarily introduced as
an anti-abuse regulation. However, following amendment to HMRC's guidance,
there has been an effective tightening of the interpretation of the Financial
Health Test. This is resulting in the restriction of potential follow-on VCT
investment to support certain portfolio companies. This has the potential to
negatively impact shareholders' returns as a result of portfolio companies
going into administration when they might otherwise have gone on to be
successful. Furthermore, as this is an industry wide issue, this measure
increases the uncertainties small companies face at a particularly difficult
time and may well result in unnecessary job losses and hardship to employees
and their families and has the potential to reduce the overall tax efficiency
of the VCT scheme as a whole.

 

The Board continues to monitor developments in this area carefully and
supports the representations being made by the AIC and the VCTA to HMRC and HM
Treasury to seek a change to HMRC's guidance in this area.

 

 

 

Outlook

The Board expects that market conditions will remain volatile throughout 2023
as the economic and political backdrop remain uncertain. While it is
anticipated that inflation will gradually start to fall later in the year, it
remains stubbornly high, and interest rates seem unlikely to fall and may rise
further over the coming months.

Against this the Company's portfolio remains highly diversified, and is
largely positioned in sectors which the Manager expect to provide long‑term
growth potential. We remain committed to investing through the economic cycle
as experience suggests that this can produce superior returns over the longer
term. This can also provide an opportunity for the Company to make high
quality investments and build strategic stakes in businesses with great
potential at good prices. This applies to both

new investments and follow‑on investments in the portfolio. The Manager
continues to see a good pipeline of potential investments and the Company
remains suitably resourced to support investment into new and existing
portfolio companies.

 

 

Fiona Miller Smith

Chair

12 June 2023

Investments in the period

 Company                       Location             Sector                               Activity                                                Book cost

                                                                                                                                                 £'000
 Unquoted investments

 New
 Cognassit UK Ltd              Newcastle upon Tyne  Healthcare & Education               A platform for supporting those with learning needs     896
 Connect Earth Ltd             London               Business Services                    Helps businesses track their carbon emissions           447
 Follow on
 Patchworks Integration Ltd    Nottingham           Technology                           A platform for connecting businesses applications       1,920
 Total unquoted investments                                                                                                                      3,263
 AIM-traded Investments
 New
 SEEEN plc                     London               Technology                           A video technology business                             609
 Oberon Investments Group plc  London               Business Services                    Wealth advisory service for individuals and businesses  471
 Total AIM-traded investments                                                                                                                    1,080
 Total investments in the period                                                                                                                 4,343

 

Realisations in the period

There were no realisations in the period.

Responsibility statement of the Directors in respect of the half-yearly
financial report

Half-yearly report

The important events that have occurred during the period under review, the
key factors influencing the financial statements and the principal
uncertainties for the remaining six months of the financial year are set out
in the Chair's statement and the Strategic report.

 

The principal risks facing the Company are mostly unchanged since the date of
the Company's Annual Report for the financial year ended 30 September 2022
and continue to be as set out in that Report on pages 18 and 19.

Risks faced by the Company include but are not limited to; loss of approval as
a Venture Capital Trust, legislative risk, investment performance risk, risk
of economic, political and other external factors, regulatory and compliance
risk and operational risk. The Board considers the aftermath of the COVID‑19
pandemic and the Russian invasion of Ukraine to be factors which permeate
these risks, and their impacts for the remaining six months of the year
continue to be kept under review.

Responsibility statement

Each Director confirms that to the best of their knowledge:

·      the condensed set of financial statements has been prepared in
accordance with FRS 104 Interim Financial Reporting Standards and gives a true
and fair view of the assets, liabilities, financial position and profit or
loss of the Company.

 

·      This half-yearly report includes a fair review of the
information required by:

 

a)   DTR 4.2.7R of the Disclosure Guidance and Transparency Rules, being an
indication of

important events that have occurred during the first six months of the
financial year and their impact on the condensed set of financial statements;
and a description of the principal risks and uncertainties for the remaining
six months of the year; and

b)   DTR 4.2.8R of the Disclosure Guidance and Transparency Rules, being
related party

transactions that have taken place in the first six months of the current
financial year and that have materially affected the financial position or
performance of the Company during that period; and any changes in the related
party transactions described in the last annual report that could do so.

 

The half-yearly report was approved by the Board of Directors on 12 June 2023
and was signed on its behalf by Ms Fiona Miller Smith, Chair.

 

Fiona Miller Smith

Chair

12 June 2023

 

 

 

 

Condensed Income Statement

For the six months to 31 March 2023 (unaudited)

 

 

 

 

                                                                                    Six months to              Six months to                Year to 30 September 2022

31 March 2023
31 March 2022
                                                                             Notes  Revenue  Capital  Total    Revenue  Capital   Total     Revenue    Capital    Total

                                                                                    £'000    £'000    £'000    £'000    £'000     £'000     £'000      £'000      £'000

 Losses on investments                                                       5      -        (1,243)  (1,243)  -        23,346    23,346    -          43,626     43,626
 Income                                                                             925      -        925      735      -         735       3,949      -          3,949
 Investment management fee                                                          (437)    (1,315)  (1,752)  (505)    (1,513)   (2,018)   (967)      (2,903)    (3,870)
 Other expenses                                                                     (336)    -        (336)    (361)    -         (361)     (652)      -          (652)
 Profit /(Loss) before taxation                                                     152      (2,558)  (2,406)  (131)    (24,859)  (24,990)  2,330      (46,529)   (44,199)
 Taxation on ordinary activities                                                    -        -        -        -        -         -         (229)      229        -
 Profit/(loss) for the period, being the total comprehensive income for the         152      (2,558)  (2,406)  (131)    (24,859)  (24,990)  2,101      (46,300)   (44,199)
 period after taxation
 Return per ordinary share:
 Basic and Diluted                                                                  0.05p    (0.80p)  (0.75p)  (0.05p)  (8.54p)   (8.59p)

                                                                             2                                                              0.69p      (15.25p)   (14.56p)

All items in the above statement derive from continuing operations.

 

There are no recognised gains and losses other than those disclosed in the
Income Statement.

 

The revenue column of the Income Statement includes all income and expenses.
The capital column accounts for the realised and unrealised profit or loss on
investments and the proportion of the management fee charged to capital.

 

The total column of this statement is the unaudited Statement of Total
Comprehensive Income of the Company prepared in accordance with the Financial
Reporting Standard ("FRS"). The supplementary revenue return and capital
return columns are prepared in accordance with the Statement of Recommended
Practice issued by the Association of Investment Companies ("AIC SORP").

 

 

 

 

 

Condensed statement of changes in equity

 

For the six months to 31 March 2023 (Unaudited)

 

                                                                                        Non-distributable reserves                        Distributable reserves         Total

                                                                                                                                                                         £'000
                                                                                        Called-up share capital  Share       Revaluation  Capital          Revenue

                                                                                        £'000                    premium     reserve      reserve £'000    reserve

                                                                                                                  £'000      £'000                         £'000
 At 1 October 2022                                                                      34,205                   108,435     16,912       31,786           2,487         193,825
 (Loss)/profit on ordinary activities after taxation                                    -                        -           (2,307)      (251)            152           (2,406)
 Net proceeds of share issues, share buybacks & sale of shares from                     3,674                    18,970      -            (1, 516)         -             21,128
 treasury

 Dividends paid                                                                         -                        -           -            (8,458)          (663)         (9,121)
 At 31 March 2023                                                                       37,879                   127,405     14,605       21,561           1,976         203,426

 

For the six months to 31 March 2022 (Unaudited)

                                                                         Non-distributable reserves                       Distributable reserves         Total

                                                                                                                                                         £'000
                                                                         Called-up share capital  Share      Revaluation  Capital          Revenue

                                                                         £'000                    Premium    reserve      reserve £'000    reserve

                                                                                                   £'000     £'000                         £'000
 At 1 October 2021                                                       29,501                   76,711     68,763       46,248           1,640         222,863
 (Loss)/ profit after taxation                                           -                        -          (28,972)     4,113            (131)         (24,990)
 Net proceeds of share issues, share buybacks & sale of shares from      4,704                    31,724     -            (850)            -             35,578
 treasury
 Dividends paid                                                          -                        -          -            (10,435)         (307)         (10,742)
 At 31 March 2022                                                        34,205                   108,435    39,791       39,076           1,202         222,709

 

For the year ended 30 September 2022 (Audited)

 

                                                                         Non-distributable reserves                        Distributable reserves         Total

                                                                                                                                                          £'000
                                                                         Called-up share capital  Share       Revaluation  Capital          Revenue

                                                                         £'000                    premium     reserve      reserve £'000    reserve

                                                                                                  £'000       £'000                         £'000
 At 1 October 2021                                                       29,501                   76,711      68,763       46,248           1,640         222,863
 (Loss)/ profit after taxation                                           -                        -           (51,851)     5,551            2,101         (44,199)
 Net proceeds of share issues, share buybacks & sale of shares from      4,704                    31,724      -            (1,050)          -             35,378
 treasury
 Dividends paid                                                          -                        -           -            (18,963)         (1,254)       (20,217)
 At 30 September 2022                                                    34,205                   108,435     16,912       31,786           2,487         193,825

 

Condensed Balance Sheet

As at 31 March 2023 (Unaudited)

 

                                                                        As at           As at

31 March 2022
30 September 2022
                                                   Notes   As at

            £'000           £'000
                                                           31 March

                                                           2023

                                                           £'000

 Fixed assets
 Unquoted investments                              5       44,426       48,012          48,184
 Traded on AIM                                     5       59,156       64,041          56,819
 Collective investment vehicles                    5       75,140       67,459          54,740
 Listed on LSE                                     5       -            24              24

 Investments                                       5       178,722      179,536         159,767

 Current assets
 Debtors                                                   1,213        80              131
 Cash at bank and on deposit                               24,600       44,304          35,051

                                                           25,813       44,384          35,182
 Creditors (amounts falling due within one year)           (1,109)      (1,211)         (1,124)

 Net current assets                                        24,704       43,173          34,058

 Net assets                                                203,426      222,709         193,825

 Capital and reserves
 Called-up share capital                                   37,879       34,205          34,205
 Share premium                                             127,405      108,435         108,435
 Capital reserve                                           21,561       39,076          31,786
 Revaluation reserve                               5       14,605       39,791          16,912
 Revenue reserve                                           1,976        1,202           2,487

 Equity shareholders' funds                                203,426      222,709         193,825

 Net asset value per share                                 57.96p       70.37p          61.29p
 Number of ordinary shares in circulation                  350,947,945  316,473,613     316,218,166

Condensed Statement of Cash Flows

For the six months to 31 March 2023 (unaudited)

 

                                                                            Six             Six         Year

months to
months to

31 March 2023
31 March   to

2022
30 September 2022
                                                                            £'000

                                                                                            £'000       £'000

 Net cash outflow from operating activities                                 (1,384)         (3,765)     (2,981)
 Net cash (outflow)/inflow from investing activities                        (21,072)        6,076       5,713
 Net cash (outflow)/inflow before financing activities                      (22,456)        2,311       2,732
 Net cash inflow from financing activities                                  12,005          24,540      14,866

 (Decrease)/increase in cash                                                (10,451)        26,851      17,598

 Reconciliation of new cash flow to movement in net cash
 (Decrease)/increase in cash                                                (10,451)        26,851      17,598
 Opening cash at bank and on deposit                                        35,051          17,453      17,453

 Closing cash at bank and on deposit                                        24,600          44,304      35,051

 Reconciliation of loss on ordinary activities before taxation to net cash
 outflow from operating activities
 Loss on ordinary activities before taxation                                (2,406)         (24,990)    (44,199)
 Losses on investments                                                      1,243           23,346      43,626
 Changes in working capital and other non-cash items                        (221)           (2,121)     (2,408)

 Net cash outflow from operating activities                                 (1,384)         (3,765)     (2,981)

 

Notes to the financial statements

 

For the six months to 31 March 2023 (Unaudited)

 

1 Basis of preparation

 

The condensed financial statements for the six months to 31 March 2023
comprise the unaudited statements set out on pages 13 to 16 together with the
related notes on pages 17 to 21. The Company applies FRS 102 and the AIC SORP
for its annual financial statements. The condensed financial statements for
the six months to 31 March 2023 have therefore been prepared in accordance
with FRS 104 'Interim Financial Reporting' and the principles of the AIC
SORP. They have been prepared on a going concern basis. The accounts have been
prepared on the same basis as the accounting policies set out in the Company's
Annual Report and Financial Statements for the year ended 30 September 2022.

 

The financial information contained in this half-yearly financial report does
not constitute statutory accounts as defined in sections 434 - 436 of the
Companies Act 2006. The half-yearly financial report for the six months ended
31 March 2023 and for the six months ended 31 March 2022 have been neither
audited nor reviewed by the Company's auditors. The information for the year
to 30 September 2022 has been extracted from the latest published audited
financial statements, which have been filed with the Registrar of Companies.
The report of the auditor for the audited financial statements for the year to
30 September 2022 has been extracted from the latest published audited
financial statements, which have been filed with the Registrars of Companies.
The report of the auditor for the audited financial statements for the year to
30 September 2022 was: (i) unqualified; (ii) did not include a reference to
any matters to which the auditor drew attention by way of emphasis without
qualifying their report; and (iii) did not contain a statement under section
498 (2) or (3) of the Companies Act 2006. No statutory accounts in respect of
any period after 30 September 2022 have been reported on by the Company's
auditors or delivered to the Registrar of Companies.

 

Copies of the half-yearly financial report have been made available to
shareholders and are available from Gresham House, 80 Cheapside, London, EC2V
6EE.

 

2   Performance and shareholder returns

 

Return per share is based on a weighted average of 321,742,586 ordinary shares
in issue (31 March 2022 - 290,940,471 ordinary shares; 30 September 2022 -
303,530,368 ordinary shares).

 

Earnings for the first six months to 31 March 2023 should not be taken as a
guide to the results of the full financial year to 30 September 2023.

 

3.  Called-up share capital

 

Allotted, called-up and fully paid:

 

 Ordinary shares                                                               £'000
 342,045,641 ordinary shares of 10p each listed at 30 September 2022           34,205
 36,739,031 ordinary shares of 10p each issued during the period               3,674
 378,784,672 ordinary shares of 10p each listed at 31 March 2023               37,879
 25,827,475 ordinary shares of 10p each held in treasury at 30 September 2022  (2,583)
 2,742,252 ordinary shares of 10p each repurchased during the period and held  (274)
 in treasury
 733,000 ordinary shares of 10p each sold from treasury during the period      73
 27,836,727 ordinary shares of 10p each held in treasury at 31 March 2023      (2,784)
 350,947,945 ordinary shares of 10p each in circulation* at 31 March 2023      35,095
 * Carrying one vote each.

 

During the six months to 31 March 2023, the Company issued 36,739,031 shares
at net proceeds of 22,334,000 (after costs). During the same period, the
Company purchased 2,742,252 shares to be held in treasury at a cost of
£1,622,000. The Company also sold 733,000 treasury shares at a cost of
£416,000. At 31 March 2023 the Company held 27,836,727 ordinary shares in
treasury. Shares may be sold out of treasury below Net Asset Value as long as
the discount at issue is narrower than the average discount at which the
shares were bought into treasury.

Excluding treasury shares, there were 350,947,945 ordinary shares in issue at
31 March 2023 (31 March 2022 - 316,473,613 ordinary shares; 30 September
2022 - 316,218,166 ordinary shares).

 

4.  Dividends

The final dividend for the year ended 30 September 2022 of 2.75p per share
(2.55p capital, 0.2p revenue) was paid on 3 March 2023 to shareholders on the
register on 3 February 2023. The ex‑dividend date was 2 February 2023.

 

During the year to 30 September 2022, the Company paid an interim dividend on
9 September 2022 of 3.0p per share (2.7p capital, 0.3p revenue).

 

5.  Investments

 

All investments are initially recognised and subsequently measured at fair
value. Changes in fair value are recognised in the Income Statement.

 

The methods of fair value measurement are classified into a hierarchy based on
reliability of the information used to determine the valuation.

 

· Level 1 - Fair value is measured based on quoted prices in an active
market.

· Level 2 - Fair value is measured based on directly observable current
market prices or indirectly being derived from market prices.

· Level 3 - Fair value is measured using a valuation technique that is not
based on data from an observable market.

 

The valuation of unquoted investments contained within level 3 of the Fair
Value hierarchy involves key assumptions dependent upon the valuation
methodology used. The primary methodologies applied are:

 

·    Cost of recent investment

·    Earnings Multiple

·    Offer Less 10 per cent

 

The earnings multiple approach involves more subjective inputs than the cost
of recent investment and offer approaches and therefore presents a greater
risk of over or under estimation. Key assumptions for the earnings multiple
approach are the selection of comparable companies and the use of either
historic or forecast revenue or earnings, as considered most appropriate.
Other assumptions include the appropriateness of the discount magnitude
applied for reduced liquidity and other qualitative factors. These assumptions
are described in more detail in note 2.3 in the Company's Report and Financial
Statements for the year to 30 September 2022.The techniques used in the
valuation of unquoted investments have not changed materially since the date
of that Report.

 

                                                    Level 1           Level 2      Level 3
                                                    Traded            Collective              Total

                                                    on AIM   Traded   investment              £'000

                                                    £'000    on LSE   vehicles     Unquoted

                                                             £'000    £'000        £'000
 Opening book cost                                  48,212   2,315    42,931       49,397     142,855
 Opening unrealised appreciation/(depreciation)     8,607    (2,291)  11,809       (1,213)    16,912
 Opening fair value                                 56,819   24       54,740       48,184     159,767
 Movements in the period:
 Purchases at cost                                  1,080    -        38,669       3,263      43,012
 Sale - proceeds                                             -        (21,750)     (1,064)    (22,814)
 - realised gains on sales                                   -        -            1,064      1,064
 Change in unrealised appreciation/ (depreciation)  1,257    (24)     3,481        (7,021)    (2,307)
 Closing fair value                                 59,156   -        75,140       44,426     178,722
 Closing book cost                                  49,292   2,315    59,850       52,660     164,117
 Closing unrealised appreciation/(depreciation)     9,864    (2,315)  15,290       (8,234)    14,605
 Closing fair value                                 59,156   -        75,140       44,426     178,722
 Equity shares                                      59,156   -        -            16,756     75,912
 Preference Shares                                  -        -        -            17,508     17,508
 Loan notes                                         -        -        -            10,162     10,162
 Collective investment vehicles                     -        -        75,140       -          75,140
 Closing fair value                                 59,156   -        75,140       44,426     178,722

 

6.  Other required disclosures

 

6.1 Segmental reporting

 

The Company has one reportable segment being investing in primarily a
portfolio of UK growth businesses, whether unquoted or traded on AIM.

 

6.2 Principal risks and uncertainties

 

The Company's financial instruments consist of equity and fixed interest
investments, cash balances and liquid resources. Its principal risks are
therefore market risk, price risk, credit risk and liquidity risk. Other risks
faced by the Company include loss of approval as a Venture Capital Trust,
legislative, investment performance, economic, political and other external
factors, regulatory and compliance and operational risks. These risks, and the
way in which they are managed, are described in more detail in the principal
risks and uncertainties table within the Strategic report section in the
Company's Report and Financial Statements for the year to 30 September 2022.
The Board continues to regularly review the risk environment in which the
Company operates.

 

6.3 Related parties

 

Gresham House Asset Management Ltd (the "Manager") manages the investments of
the Company. The Manager also provides or procures the provision of
secretarial, administrative and custodian services to the Company. Under the
management agreement, the Manager receives a fee of 2.0 per cent. per annum
of the net assets of the Company. This is described in more detail under the
heading 'The management agreement' within the Strategic Report in the
Company's Annual Report and Financial Statements for the year to 30 September
2022. During the period the Company has incurred management fees of
£1,753,000 (31 March 2022 - £2,018,000; 30 September 2022 - £3,870,000)
and secretarial fees of £74,000 (31 March 2022 - £69,000; 30 September
2022 - £136,000) payable to the Manager. A performance fee of £nil has been
accrued at 31 March 2023 (31 March 2022 - £nil; 30 September 2022 -
£nil). This is described in more detail under the heading 'Performance fees'
within the Strategic Report in the Company's Annual Report and Financial
Statements for the year to 30 September 2022.

 

6.4 Going Concern

 

After making enquiries, and bearing in mind the nature of the Company's
business and assets, the Directors consider that the Company has adequate
resources to continue in operational existence for the foreseeable future. In
arriving at this conclusion, the Directors have considered the Company's cash
balances, the liquidity of the Company's investments and the absence of any
gearing. The Directors are therefore also satisfied that the Company has
adequate financial resources to continue in operation for at least the next 12
months and that, accordingly, it is appropriate to adopt the going concern
basis in preparing the financial statements.

 

 

 

 

 

6.5   Post balance sheet events

The following events occurred between the balance sheet date and the signing
of these financial statements:

 

·      The 30 April 2023 NAV of 59.0p was announced on 5 May 2023 and
the 31 May 2023 NAV of 59.1p was announced on 6 June 2023. At the date of
publishing this report, the Board is unaware of any matter that will have
caused the NAV per share to have changed significantly since the latest NAV.

 

·      3 million shares were issued on 3 April 2023 at allotment prices
between 58.9p and 61.8p under the current offer.

 

·      Purchased 0.7 million Ordinary Shares of 10.0p on 5 April 2023 at
a price of 54.3p per share to be held in Treasury.

 

·      Follow‑on investment into Airfnity Ltd completed in April 2023
totalling £0.6mn.

 

·      Follow‑on investment into Panthera Biopartners completed in
June 2023 totalling £0.4mn.

 

·      Two follow‑on investments, into Multi Cap, completed in April
and May 2023, totalling £2.5mn.

 

·      Two follow‑on investments, into Small Cap, completed in April
and May 2023, totalling £2.5mn.

 

·      One new investment, into Dayrize B.V., completed in May 2023
totalling £0.8mn.

 

·      Partial realisation in MXC Capital Ltd was made in April,
following a corporate action, realising proceeds of £0.01mn and making a
return of 0.6x cost.

 

·      Partial realisations in Cerillion plc were made in April and May,
realising proceeds of £0.5mn and making a return of 15.8x cost.

 

·      Received deferred proceeds of £1.1mn from Pho in May 2023, which
was realised in July 2021, making a total return of 3.1x cost.

 

·      Realised Evotix in May 2023, receiving proceeds of £0.7mn,
making a return of 0.7x cost.

 

·      Received deferred proceeds of £0.3mn from Key Travel in May
2023, which was realised in May 2018, making a total return of 3.2x cost.

 

 

 

 

 

 

 Directors                            Registrars and Transfer Office

 Fiona Miller Smith (Chair)           Computershare Investor Services PLC

 Les Gabb*                            The Pavilions

 Susannah Nicklin Δ†                  Bridgwater Road

 Michael Probin††                     Bristol BS99 6ZZ

                                      Tel: 0800 923 1533

 Secretary

 Gresham House Asset Management Ltd   Brokers

                                      Panmure Gordon & Co

 Registered Office                    One New Change

 5 New Street Square                  London EC4M 9AF

 London EC4A 3TW                      Tel: 020 7886 2500

 Investment Manager                   Auditor

 Gresham House Asset Management Ltd   BDO LLP

 5 New Street Square                  55 Baker Street

 London EC4 3TW                       London W1U 7EU

 Tel: 020 7382 0999

                                      Solicitors

 Registered Number                    Dickson Minto W.S

 03504214                             Broadgate Tower

                                      20 Primrose Street

                                      London EC2A 2EW

                                      VCT Status Adviser

                                      PricewaterhouseCoopers LLP

                                      1 Embankment Place

                                      London WC2N 6RH

                                      Website

                                      www.baronsmeadvcts.co.uk (http://www.baronsmeadvcts.co.uk/)

 Corporate Information

Δ   Senior Independent Director

*  Chair of the Audit Committee

† Chair of the Nomination Committee

††  Chair of the Management Engagement and Remuneration Committee

LEI: 213800VQ1PQHOJXDDQ88

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IR BLGDLSUBDGXD

Recent news on Baronsmead Venture Trust

See all news